Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

There’s no “I” in “Nutramax”

This article was originally published in The Tan Sheet

Executive Summary

Cosamin DS joint health supplement maker Nutramax is challenging a trademark application for Nutrimax in the U.S. for the same class of products registered under its brand name, the Edgewood, Md.-based company announces. The firm filed an opposition with the U.S. Patent and Trademark Office as well as a court complaint citing trademark infringement. The U.S. District Court for the District of Maryland July 17 granted the firm's motion for judgment by default effectively barring Los Angeles-based Nutrimax USA from advertising, promoting and/or offering to market any dietary supplement products containing the word "Nutrimax," and requires it to destroy all documents containing the word and modify all Web sites and electronic files...

You may also be interested in...



Execs On The Move: Promotions At Agilent And CHF Solutions; New Chief At Zimmer

CHF Solutions adds “CEO” to its president’s job title; Agilent VP of business development promoted to senior VP; Zimmer hires chief transformation officer; and more.

Pfizer’s Pegfilgrastim Biosimilar ‘Has Launched’ In The US

Pfizer has pressed on with the launch of a fourth biosimilar pegfilgrastim product, Nyvepria (pegfilgrastim-apgf), according to an investment bank. With Amgen continuing to hold more than 70% of the market, there is opportunity for Pfizer to capture significant market share.

EU Business Round-Up: Galenica Boosted By Deals, Alliance's Sales Rise, And Beiersdorf Relaunches Wound Care

Latest EU business news: Galenica posts sales up in 2020 thanks to deals; Alliance Pharma's Consumer sales edge up despite COVID-19; and Beiersdorf is relaunching its wound care range with sustainability in mind.

Topics

UsernamePublicRestriction

Register

OM011381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel